Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yunpi Yishen Jiedu Tongdu is a Traditional Chinese Medicine (TCM) herbal formula developed by the Zhejiang University of Traditional Chinese Medicine for the treatment of active ankylosing spondylitis and spondyloarthropathy. The formula is designed based on the TCM therapeutic principles of invigorating the spleen (Yunpi), tonifying the kidney (Yishen), clearing heat and detoxifying (Jiedu), and unblocking the Du meridian (Tongdu). It is currently being evaluated in clinical research to establish high-quality evidence for its synergistic effects and its potential to reduce the toxicity of conventional treatments, with a specific focus on preventing the progression of undifferentiated spondyloarthropathy into defined conditions like ankylosing spondylitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yunpi Yishen Jiedu Tongdu.